Zepbound prior authorization: what each insurer requires
Last updated
Where a plan covers it for weight loss, approval comes first: Aetna, Cigna and FEP Blue ask for a BMI of 30 (27 with a weight-related condition) and a weight-management program, Kansas and Virginia's state plans a BMI of 35, CalPERS and Kaiser in California 40.
If it is denied: the lowest cash prices now

If it is denied: compounded tirzepatide on a monthly plan, not FDA-approved
$69/mo + $199/yr membership · about $86 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

If it is denied: compounded semaglutide on a monthly plan, not FDA-approved
$59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before
Zepbound and Wegovy prior authorization: common questions
Does Zepbound need prior authorization?
Where a plan covers Zepbound or Wegovy for weight loss, its rules ask for approval first. Of the 20 plans whose criteria we quote here, 11 say so in so many words: UnitedHealthcare, Cigna, GEHA, CareFirst, Wellmark, CalPERS, Kansas SEHP, Illinois State Employees Group Insurance Program, Massachusetts GIC, Georgia SHBP, Meridian (Michigan). Many plans do not cover weight-loss drugs at all, and then no approval is possible for weight loss alone.
What do insurers require for Zepbound or Wegovy prior authorization?
UnitedHealthcare: UnitedHealthcare's commercial weight-loss drug program, which covers Wegovy and Zepbound with prior authorization, is an optional program for employers and other clients that chose to cover weight-loss drugs. Aetna: Aetna's Zepbound criteria for weight loss require at least 6 months in a comprehensive weight management program before drug therapy, plus a baseline BMI of 30 or more, or 27 or more with a listed weight-related condition. Cigna: Where a Cigna plan covers weight loss, Zepbound needs prior authorization: an adult with at least 3 months of behavioral modification and dietary restriction and a baseline BMI of 30 or more (or 27 or more with a listed condition) is approved for 8 months at first. Cigna's benefit-exclusion override product lets a plan that excludes weight-loss drugs still cover Zepbound for weight loss at a BMI of 35 or more, or 27 or more with at least two weight-related conditions. FEP Blue: OPM requires every federal employee plan, FEP Blue included, to cover at least one GLP-1 anti-obesity drug, and from 2027 every carrier must require documented intensive behavioral therapy before and during treatment. FEP Blue approves Wegovy injection for chronic weight management in adults with a BMI of 30 or more, or 27 or more with established cardiovascular disease or another weight-related condition, after a comprehensive weight management program. GEHA: GEHA covers Wegovy, Zepbound, Saxenda, Foundayo and generic liraglutide for weight loss on its High, Standard, HDHP and Elevate Plus plans for members who meet its prior authorization requirements. OPM requires every federal employee plan, FEP Blue included, to cover at least one GLP-1 anti-obesity drug, and from 2027 every carrier must require documented intensive behavioral therapy before and during treatment. Kaiser Permanente: Kaiser Permanente California removed weight-loss-only GLP-1 coverage from base commercial and individual plans at renewals from January 1, 2025 for members with a BMI under 40. In California, Kaiser Permanente still covers GLP-1s under the base plan at a BMI of 40 or more and when prescribed in a disease management program such as for type 2 diabetes or a major adverse cardiac event. VA: VA's April 2026 criteria for tirzepatide (Zepbound) for chronic weight management call taking part in a comprehensive lifestyle intervention essential. The same VA Zepbound criteria set the threshold at a BMI of 27 or more with at least one weight-related comorbidity. VA's April 2026 Wegovy criteria for chronic weight management say the same about the lifestyle intervention. Aetna Medicare SilverScript: A member qualifies through a standalone Part D plan or a Medicare Advantage plan with drug coverage and a qualifying BMI. Horizon Blue Cross Blue Shield of New Jersey: Horizon's weight-loss GLP-1 prior authorization policy from 1 January 2026 requires a BMI of at least 35 with at least one comorbidity and active participation in a weight management program. Blue Cross NC: Blue Cross NC says its GLP-1 for Weight Management program (launched 1 January 2025) is available to ASO (self-funded) plans. CareFirst: CareFirst told providers in July 2023 that for members whose plan includes weight loss medications as a covered benefit, only GLP-1s FDA-approved for obesity are covered, with specific prior authorization. Wellmark: Wellmark calls drugs for weight loss management a standard exclusion for most benefit plans, with prior authorization applied where the plan's drug benefit includes them. Wellmark's criteria apply only to select plans with specific benefit language allowing weight-loss drug coverage. CalPERS: CalPERS's Knox-Keene HMO plans from Blue Shield and Kaiser cover GLP-1 drugs for morbid obesity (BMI 40 or higher), with prior authorization. Kansas SEHP: Since January 1, 2026, the Kansas State Employee Health Plan covers GLP-1s for weight management only for members with a BMI of 35 or more. Every anti-obesity medication needs prior authorization from Caremark. Virginia state employee health plan: Members already approved who stay compliant are not held to the new BMI 35 rule when their approval renews. Illinois State Employees Group Insurance Program: Every health plan in Illinois' State Employees Group Insurance Program covers medically necessary injectable weight-loss medication for adults with obesity, prediabetes or gestational diabetes, from July 1, 2024. To stay covered, the treatment must remain medically necessary and members may be asked to join a lifestyle management plan. Massachusetts GIC: From July 1, 2026 these prescriptions need prior authorization through CVS. Georgia SHBP: The prescriptions still need prior authorization and must meet the plan's coverage rules. Meridian (Michigan): From January 1, 2026, approval needs morbid obesity, failure of other weight-loss treatments and of preferred drugs, and use only to avoid bariatric surgery. HAP CareSource (Michigan): A request for obesity now needs the patient to be classified as morbidly obese, among other criteria. Each plan's own words are quoted under its name on this page.
How long does Zepbound prior authorization take?
UnitedHealthcare Medicare (AARP plans): UnitedHealthcare says a Bridge prior authorization is decided within 72 hours of submission. In its words: "Approval or denial is communicated back to you and your patient within 72 hours of submission." (UnitedHealthcare, Medicare GLP-1 Bridge program: What you need to know (UHCprovider.com), uhcprovider.com, read Nov 19, 2026). None of the other plans' pages we read gives a time.
How long does a Zepbound prior authorization last?
Cigna: Where a Cigna plan covers weight loss, Zepbound needs prior authorization: an adult with at least 3 months of behavioral modification and dietary restriction and a baseline BMI of 30 or more (or 27 or more with a listed condition) is approved for 8 months at first. In its words: "A) Initial Therapy. Approve for 8 months if the patient meets ALL of the following (i, ii, iii, and iv): i. Patient is ≥ 18 years of age; AND ii. Patient has engaged in a trial of behavioral modification and dietary restriction for at least 3 months; AND" (Cigna Drug Coverage Policy IP0816, Weight Loss - Glucagon-Like Peptide-1 Agonists - Zepbound, effective 09/01/2026, static.cigna.com, read Nov 17, 2026). Virginia state employee health plan: Members already approved who stay compliant are not held to the new BMI 35 rule when their approval renews. In its words: "Members who are currently using GLP 1 weight loss medications under an active PA, and remain continuously compliant, will not be required to meet the new BMI ≥ 35 criteria when their PA renews." (Virginia Department of Human Resource Management, Health Benefits E-News, August 12, 2026, content.govdelivery.com/accounts/VADHRM/bulletins/424742e, read Nov 19, 2026). The other plans' pages we read give no length.
My prior authorization for Zepbound was denied. What now?
Pay cash, at the self-pay prices: Zepbound costs $299/28 days at 2.5 mg and $449/28 days at 15 mg without insurance at Amazon Pharmacy and LillyDirect (Eli Lilly), checked Nov 19, 2026 on pharmacy.amazon.com and zepbound.lilly.com. At 15 mg, the terms: at Amazon Pharmacy, through Dec 31, 2026, with Lilly's self-pay card, whose terms on Lilly's Zepbound savings page say "Card expires and savings end on 12/31/2026" and require each refill within 45 days of the previous delivery, or Lilly's regular $699 applies; at LillyDirect (Eli Lilly), Self Pay Journey price with a refill within 45 days; otherwise $499 at 7.5 mg or $699 at 10 to 15 mg. Wegovy costs $199/28 days, through Dec 31, 2026 at 0.25 mg and $349/28 days at 2.4 mg without insurance at Amazon Pharmacy and NovoCare (Novo Nordisk), checked on pharmacy.amazon.com Nov 19, 2026 and on novocare.com Nov 11, 2026. Compounded, not FDA-approved: compounded tirzepatide from $69/mo + $199/yr membership at Collective (about $86 a month over a year with the membership); compounded semaglutide from $59/mo + $199/yr membership at Collective (about $76 a month over a year with the membership). If you have obstructive sleep apnea, some plans cover Zepbound for that use under criteria of their own (Aetna, Cigna, FEP Blue, Kaiser Permanente, CVS Caremark, Massachusetts GIC, Mississippi State and School Employees' Health Plan among the plans here). Every GLP-1's cash price without insurance
Each plan's criteria, in its own words
- Does UnitedHealthcare cover Zepbound or Wegovy? Only if your employer's plan chose to cover weight-loss drugs.
UnitedHealthcare's commercial weight-loss drug program, which covers Wegovy and Zepbound with prior authorization, is an optional program for employers and other clients that chose to cover weight-loss drugs. In its words: "This is an optional program that is put in place for clients or businesses that have elected to cover weight loss products with Prior Authorization/Notification." (UnitedHealthcare Clinical Pharmacy Programs, Prior Authorization/Notification - Weight Loss/Appetite Suppression, program 2026 P 1114-23, effective 10/1/2026, uhcprovider.com, read Nov 17, 2026).
- Does Aetna cover Zepbound or Wegovy? Only if your plan covers weight-loss drugs, after a weight program.
Aetna's Zepbound criteria for weight loss require at least 6 months in a comprehensive weight management program before drug therapy, plus a baseline BMI of 30 or more, or 27 or more with a listed weight-related condition. In its words: "The patient has participated in a comprehensive weight management program that encourages behavioral modification, reduced-calorie diet, AND increased physical activity with continuing follow-up for at least 6 months prior to using drug therapy." (Aetna Non-Medicare Prescription Drug Plan, Specialty Pharmacy Clinical Policy Bulletin, Zepbound PA with Limit 6192-C 08-2026 v3 (last reviewed 09/16/2026), aetna.com, read Nov 17, 2026).
- Does Cigna cover Zepbound or Wegovy? Many Cigna plans exclude weight-loss drugs; covered plans need prior authorization.
Where a Cigna plan covers weight loss, Zepbound needs prior authorization: an adult with at least 3 months of behavioral modification and dietary restriction and a baseline BMI of 30 or more (or 27 or more with a listed condition) is approved for 8 months at first. In its words: "A) Initial Therapy. Approve for 8 months if the patient meets ALL of the following (i, ii, iii, and iv): i. Patient is ≥ 18 years of age; AND ii. Patient has engaged in a trial of behavioral modification and dietary restriction for at least 3 months; AND" (Cigna Drug Coverage Policy IP0816, Weight Loss - Glucagon-Like Peptide-1 Agonists - Zepbound, effective 09/01/2026, static.cigna.com, read Nov 17, 2026).
Cigna's benefit-exclusion override product lets a plan that excludes weight-loss drugs still cover Zepbound for weight loss at a BMI of 35 or more, or 27 or more with at least two weight-related conditions. In its words: "This Benefit Exclusion Overrides policy has been developed to authorize coverage of Zepbound for the treatment of weight loss in adults with a body mass index (BMI) of ≥ 27 kg/m2 with at least two weight-related comorbidities, or with a body mass index of ≥ 35 kg/m2." (Cigna Drug Coverage Policy BEO014, Zepbound Benefit Exclusion Overrides Policy BMI ≥ 35, effective 09/01/2026, static.cigna.com, read Nov 17, 2026).
- Does FEP Blue cover Zepbound or Wegovy? Yes, with prior authorization: federal plans must cover a GLP-1 for weight loss.
OPM requires every federal employee plan, FEP Blue included, to cover at least one GLP-1 anti-obesity drug, and from 2027 every carrier must require documented intensive behavioral therapy before and during treatment. In its words: "Plans will continue to cover at least one GLP-1 anti-obesity medication and at least two oral anti-obesity medications. For 2027, all FEHB and PSHB Carriers will require documented participation in an evidence-based intensive behavioral therapy (IBT) program both prior to and during treatment with anti-obesity medications." (U.S. Office of Personnel Management, Federal Benefits Open Season Highlights, 2027 Plan Year, opm.gov, read Nov 17, 2026).
FEP Blue approves Wegovy injection for chronic weight management in adults with a BMI of 30 or more, or 27 or more with established cardiovascular disease or another weight-related condition, after a comprehensive weight management program. In its words: "a. Age 18+, must have ONE of the following: i. Body mass index (BMI) ≥ 30 kg/m2 ii. Body mass index (BMI) ≥ 27 kg/m2 AND ONE of the following: 1. Patient has established cardiovascular disease" (FEP Blue pharmacy policy 5.99.030 Saxenda Wegovy, effective July 1, 2026, www1.fepblue.org, read Nov 17, 2026).
- Does GEHA cover Zepbound or Wegovy? Yes, with prior authorization, as non-preferred drugs on most GEHA plans.
GEHA covers Wegovy, Zepbound, Saxenda, Foundayo and generic liraglutide for weight loss on its High, Standard, HDHP and Elevate Plus plans for members who meet its prior authorization requirements. In its words: "For members enrolled in the High, Standard, HDHP and Elevate Plus plans, the following GLP-1s are covered by the plan for members who meet the prior authorization (PA) requirements:" (GEHA, Pharmacy coverage for weight loss GLP-1 medications, updated 10/01/2026, geha.com, read Nov 17, 2026).
OPM requires every federal employee plan, FEP Blue included, to cover at least one GLP-1 anti-obesity drug, and from 2027 every carrier must require documented intensive behavioral therapy before and during treatment. In its words: "Plans will continue to cover at least one GLP-1 anti-obesity medication and at least two oral anti-obesity medications. For 2027, all FEHB and PSHB Carriers will require documented participation in an evidence-based intensive behavioral therapy (IBT) program both prior to and during treatment with anti-obesity medications." (U.S. Office of Personnel Management, Federal Benefits Open Season Highlights, 2027 Plan Year, opm.gov, read Nov 17, 2026).
- Does Kaiser Permanente cover Zepbound or Wegovy? It depends on the region; in California, at a BMI of 40 or more unless a rider is bought.
Kaiser Permanente California removed weight-loss-only GLP-1 coverage from base commercial and individual plans at renewals from January 1, 2025 for members with a BMI under 40. In its words: "Effective with contract renewal on or after January 1, 2025, coverage for GLP-1 drugs and other AOMs will be removed from base coverage in California commercial and Individual & Family plans when those drugs are prescribed solely for the purpose of weight loss for patients with BMI less than 40." (Kaiser Permanente California employer news, Changes for GLP-1 drugs & other Anti-Obesity Medications in 2025 (Wayback Machine copy of 2025-10-18; the live page answers 404 on 2026-11-17), web.archive.org, read Nov 17, 2026).
In California, Kaiser Permanente still covers GLP-1s under the base plan at a BMI of 40 or more and when prescribed in a disease management program such as for type 2 diabetes or a major adverse cardiac event. In its words: "Per California Title 28 Rule 1300.67.24(e)(3), GLP-1 drugs and other AOMs will still be covered under the base plan for patients with BMI equal to or greater than 40. Coverage remains unchanged for GLP-1’s and other AOMs, when prescribed as part of a disease management program for medical conditions (for example, Type 2 Diabetes or Major Adverse Cardiac Event)." (Kaiser Permanente California employer news, Changes for GLP-1 drugs & other Anti-Obesity Medications in 2025 (Wayback Machine copy of 2025-10-18; the live page answers 404 on 2026-11-17), web.archive.org, read Nov 17, 2026).
- Does VA cover Zepbound or Wegovy? Covered for veterans meeting criteria: lifestyle program and BMI 27+.
VA's April 2026 criteria for tirzepatide (Zepbound) for chronic weight management call taking part in a comprehensive lifestyle intervention essential. In its words: "Participation in a CLI is an essential component to overall weight management." (VA Formulary Advisor, Tirzepatide (Zepbound) weight management criteria for use, April 2026, va.gov, read Nov 19, 2026).
The same VA Zepbound criteria set the threshold at a BMI of 27 or more with at least one weight-related comorbidity. In its words: "BMI is greater than or equal to 27 kg/m2 with at least one weight-related comorbidity" (VA Formulary Advisor, Tirzepatide (Zepbound) weight management criteria for use, April 2026, va.gov, read Nov 19, 2026).
VA's April 2026 Wegovy criteria for chronic weight management say the same about the lifestyle intervention. In its words: "Participation in a CLI is an essential component to overall weight management." (VA Formulary Advisor, Semaglutide (Wegovy) weight management criteria for use, April 2026, va.gov, read Nov 19, 2026).
- Does Aetna Medicare SilverScript cover Zepbound or Wegovy? Not through the plan itself; Medicare's GLP-1 Bridge charges $50 a month.
A member qualifies through a standalone Part D plan or a Medicare Advantage plan with drug coverage and a qualifying BMI. In its words: "You may qualify if you are enrolled in a standalone Medicare Part D plan or a Medicare Advantage plan with drug coverage and you have a body mass index greater than or equal to 35 or a body mass index greater than or equal to 30 with a related health condition." (Aetna Medicare: Medicare GLP-1 Bridge coverage and eligibility, aetna.com, read Nov 17, 2026).
- Does Horizon Blue Cross Blue Shield of New Jersey cover Zepbound or Wegovy? Not under select Horizon plans since Oct 1, 2026, except for MASH.
Horizon's weight-loss GLP-1 prior authorization policy from 1 January 2026 requires a BMI of at least 35 with at least one comorbidity and active participation in a weight management program. In its words: "Meeting a BMI of at least 35kg/m² with at least one comorbidity in accordance with recommended guidelines - Participation and active engagement in a weight management program" (Horizon BCBSNJ provider news, New Requirements for GLP-1 Medications for Weight Loss, horizonblue.com, Oct 1, 2025, read Nov 17, 2026).
- Does Blue Cross NC cover Zepbound or Wegovy? Not a standard benefit; self-funded employer plans can add it.
Blue Cross NC says its GLP-1 for Weight Management program (launched 1 January 2025) is available to ASO (self-funded) plans. In its words: "The GLP-1 for Weight Management program is available to ASO plans." (Blue Cross NC provider news, New and expanded member programs effective January 1, bluecrossnc.com, Jan 10, 2025, read Nov 17, 2026).
- Does CareFirst cover Zepbound or Wegovy? Only if your plan includes weight loss medications.
CareFirst told providers in July 2023 that for members whose plan includes weight loss medications as a covered benefit, only GLP-1s FDA-approved for obesity are covered, with specific prior authorization. In its words: "For members whose plan includes weight loss medications as a covered benefit, only GLP-1s that are FDA-approved to treat obesity are covered and must be obtained via specific prior authorization criteria that ensures appropriate use of those agents." (CareFirst provider news, Coverage Reminders for GLP-1 Receptor Agonists, provider.carefirst.com, Jul 20, 2023, read Nov 17, 2026).
- Does Wellmark cover Zepbound or Wegovy? A standard exclusion for most plans; covered where the plan adds it.
Wellmark calls drugs for weight loss management a standard exclusion for most benefit plans, with prior authorization applied where the plan's drug benefit includes them. In its words: "Drugs for weight loss management or weight related comorbidities are a standard exclusion for most benefit plans. When the member’s prescription drug benefit language includes coverage for weight loss products, prior authorization review for medical necessity will be applied." (Wellmark Drug Policy, Drugs for Weight Loss Management, effective Sep. 1, 2026, digital-assets.wellmark.com, read Nov 17, 2026).
Wellmark's criteria apply only to select plans with specific benefit language allowing weight-loss drug coverage. In its words: "criteria only applies to select plans with specific benefit language to allow coverage of drugs for weight loss management or for weight related comorbidities when prior authorization criteria is met." (Wellmark Drug Policy, Drugs for Weight Loss Management, effective Sep. 1, 2026, digital-assets.wellmark.com, read Nov 17, 2026).
- Does CalPERS cover Zepbound or Wegovy? Only for BMI 40 or higher on some HMO plans.
CalPERS's Knox-Keene HMO plans from Blue Shield and Kaiser cover GLP-1 drugs for morbid obesity (BMI 40 or higher), with prior authorization. In its words: "CalPERS’ Knox-Keene regulated plans that manage their own pharmacy benefit, including HMO plans offered by Blue Shield of California and Kaiser Permanente, cover GLP-1 medications for morbid obesity (BMI ≥ 40 kg/m2), subject to prior authorization requirements." (CalPERS Board Agenda Item 8c, SB 1089 position, June 17, 2026, calpers.ca.gov/documents/202606-full-agenda-item8c-00-a/download, read Nov 19, 2026).
- Does Kansas SEHP (state employee plans) cover Zepbound or Wegovy? Covers weight-loss GLP-1s only at a BMI of 35 or more, with prior authorization; Wegovy is preferred.
Since January 1, 2026, the Kansas State Employee Health Plan covers GLP-1s for weight management only for members with a BMI of 35 or more. In its words: "Patients must have a Body Mass Index (BMI) of 35 or higher to qualify for coverage of GLP-1s for weight management. This criterion applies to all GLP-1 prescriptions for weight management issued or renewed after Jan. 1, 2026." (Kansas State Employee Health Plan, GLP-1s, sehp.healthbenefitsprogram.ks.gov/glp-1s, Jan 1, 2026, read Nov 19, 2026).
Every anti-obesity medication needs prior authorization from Caremark. In its words: "All Anti-Obesity Medications require prior authorization by Caremark." (Kansas State Employee Health Plan, GLP-1s, sehp.healthbenefitsprogram.ks.gov/glp-1s, read Nov 19, 2026).
- Does the Virginia state employee health plan cover Zepbound or Wegovy? Covered with prior authorization; new users need a BMI of 35 or more since July 1, 2026.
Members already approved who stay compliant are not held to the new BMI 35 rule when their approval renews. In its words: "Members who are currently using GLP 1 weight loss medications under an active PA, and remain continuously compliant, will not be required to meet the new BMI ≥ 35 criteria when their PA renews." (Virginia Department of Human Resource Management, Health Benefits E-News, August 12, 2026, content.govdelivery.com/accounts/VADHRM/bulletins/424742e, read Nov 19, 2026).
- Does the Illinois State Employees Group Insurance Program cover Zepbound or Wegovy? Covered when medically necessary for adults with obesity, by state law since July 2024.
Every health plan in Illinois' State Employees Group Insurance Program covers medically necessary injectable weight-loss medication for adults with obesity, prediabetes or gestational diabetes, from July 1, 2024. In its words: "Effective July 1, 2024, per 5 ILCS 375/6.11c, all health plans under the State Employees Group Insurance Program will provide coverage for all types of medically necessary injectable medication prescribed to improve glucose or weight loss for use by adults (age 18 and over) that have been diagnosed with prediabetes, gestational diabetes, or obesity." (Illinois Department of Central Management Services, State Employee Benefits, Summary of Benefits and Coverage, cms.illinois.gov, Jul 1, 2024, read Nov 19, 2026).
To stay covered, the treatment must remain medically necessary and members may be asked to join a lifestyle management plan. In its words: "To continue to qualify for coverage under this Section, the continued treatment must be medically necessary, and covered members must, if given advance, written notice, participate in a lifestyle management plan administered by their health plan." (5 ILCS 375/6.11C, Illinois Compiled Statutes, ilga.gov/legislation/ilcs/documents/000503750K6.11C.htm, read Nov 19, 2026).
- Does Massachusetts GIC (state employee plans) cover Zepbound or Wegovy? Not for weight loss alone since July 1, 2026; heart disease, sleep apnea or MASH may still qualify.
From July 1, 2026 these prescriptions need prior authorization through CVS. In its words: "Medications will require prior authorization through CVS" (GIC, April Update on Vida Health Program and GLP-1 Coverage, mass.gov/news/update-on-vida-health-program-and-glp-1-coverage, Jul 1, 2026, read Nov 19, 2026).
- Does Georgia SHBP (state employee plans) cover Zepbound or Wegovy? Covers weight-loss medications with prior authorization; any doctor may prescribe them since October 2026.
The prescriptions still need prior authorization and must meet the plan's coverage rules. In its words: "Weight loss prescriptions must comply with prior authorization and benefit coverage rule requirements." (Georgia State Health Benefit Plan, Changes to Weight Management Program Effective October 1, 2026, shbp.georgia.gov, read Nov 19, 2026).
- Does Meridian (Michigan) cover Zepbound or Wegovy? Michigan cut obesity-only GLP-1 coverage in January 2026; strict criteria apply.
From January 1, 2026, approval needs morbid obesity, failure of other weight-loss treatments and of preferred drugs, and use only to avoid bariatric surgery. In its words: "Starting 01/01/2026, in order to be approved for coverage the patient must be classified as morbidly obese, have documented failure of all other clinically appropriate weight-loss interventions, trial and failure of Preferred Drug List [PDL] preferred anti-obesity agents, and the agent must be used only as a measure to avert the need for bariatric surgery." (Meridian, MI Medicaid Anti-Obesity/Weight Loss GLP-1 Agent Benefit Reduction, mimeridian.com/providers/bulletins/122025-glp1-benefit-reduction.html, Jan 1, 2026, read Nov 19, 2026).
- Does HAP CareSource (Michigan) cover Zepbound or Wegovy? Michigan cut obesity-only GLP-1 coverage in January 2026; morbid obesity is now required.
A request for obesity now needs the patient to be classified as morbidly obese, among other criteria. In its words: "Patient must be classified as morbidly obese; and" (HAP CareSource, Update of Pharmacy Drug Coverage for Treatment of Obesity (provider notice), caresource.com, read Nov 19, 2026).
GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.